Back to Search
Start Over
Prevalence of obesity and obesity-associated muscle wasting in patients on peritoneal dialysis.
- Source :
-
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2019 Dec; Vol. 29 (12), pp. 1390-1399. Date of Electronic Publication: 2019 May 16. - Publication Year :
- 2019
-
Abstract
- Background and Aims: A progressive decrease in muscle mass until full-blown sarcopenia may occur in patients on peritoneal dialysis (PD) and worsen their life quality and expectancy. Here we investigate the prevalence of obesity and obesity-associated muscle wasting in PD patients.<br />Patients and Methods: The study design was observational, cross sectional. Body composition was assessed with BIA and BIVA in 88 PD patients (53.4 ± 13.1 years; 67% male). Patients with obesity and/or with reduced muscle mass were identified using FMI and SM/BW cutoff values, respectively. Inflammatory status was assessed by measuring CRP and fibrinogen blood levels.<br />Results: A total of 44.3% of the patients showed a reduced muscle mass (37.5% moderate and 6.8% severe). The prevalence of obesity was 6.1%, 81.8%, and 100% in patients with normal, moderately, and severely reduced muscle mass, respectively (p < 0.05). Of the total, 15.2% of the patients with normal muscle mass, 18.4% of those with moderately reduced muscle mass, and 66.7% of those with severely reduced muscle mass had diabetes. The prevalence of severe muscle mass loss was higher in those with diabetes than in those without diabetes (22.2% vs. 2.8%, p < 0.05). Patients with obesity-associated muscle wasting showed higher fibrinogen (613.9 ± 155.1 vs. 512.9 ± 159.5 mg/dL, p < 0.05) and CPR (1.4 ± 1.3 vs. 0.6 ± 0.8 mg/dL, p < 0.05) blood concentrations than those with normal body composition.<br />Conclusion: Obesity and diabetes were strongly associated with muscle mass loss in our PD patients. It remains to be established whether prevention of obesity with nutritional interventions can halt the occurrence of muscle mass loss in patients on PD.<br /> (Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Adult
Aged
Biomarkers blood
Body Composition
C-Reactive Protein
Cross-Sectional Studies
Diabetes Mellitus epidemiology
Female
Fibrinogen
Humans
Inflammation Mediators blood
Italy epidemiology
Kidney Failure, Chronic diagnosis
Kidney Failure, Chronic epidemiology
Kidney Failure, Chronic physiopathology
Male
Middle Aged
Obesity blood
Obesity diagnosis
Obesity physiopathology
Prevalence
Risk Assessment
Risk Factors
Sarcopenia blood
Sarcopenia diagnosis
Sarcopenia physiopathology
Kidney Failure, Chronic therapy
Obesity epidemiology
Peritoneal Dialysis adverse effects
Sarcopenia epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1590-3729
- Volume :
- 29
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Nutrition, metabolism, and cardiovascular diseases : NMCD
- Publication Type :
- Academic Journal
- Accession number :
- 31668791
- Full Text :
- https://doi.org/10.1016/j.numecd.2019.05.057